Skip to main content

Massacesi Cristian's Form 4 filing

Bristol Myers Squibb Co (BMY) · filed Aug 4, 2026

Accession no.
0002080176-26-000004
Filed
Aug 4, 2026, 4:10 PM ET
Trade date
Aug 1, 2026
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Massacesi CristianCIK 0002080176Officer (EVP,Chief Med Offr,Head of Dev)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 1, 2026Common Stock, $0.10 par valueMOption exerciseAcquired+51,172$0.00$051,172Direct
Aug 1, 2026Common Stock, $0.10 par valueFTax withholdingDisposed−26,175$65.31−$1,709,489.2524,997Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 1, 2026Common Stock, $0.10 par valueMOption exerciseDisposed−51,172$0.00$0153,519Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)